Novavax (NVAX) News Today $9.46 -0.09 (-0.94%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$9.46 +0.00 (+0.05%) As of 10/3/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NVAX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period A Fresh Look at Novavax (NVAX) Valuation After Recent Share Price ReboundOctober 3 at 4:09 PM | finance.yahoo.comInvestors Purchase Large Volume of Call Options on Novavax (NASDAQ:NVAX)October 2 at 3:01 PM | marketbeat.comNovavax (NASDAQ:NVAX) Trading 6.4% Higher - What's Next?October 1 at 12:44 PM | marketbeat.comNovavax Amends Deal With Sanofi, Broadens PartnershipSeptember 30, 2025 | msn.comNovavax Announces Progress on Sanofi AgreementSeptember 30, 2025 | prnewswire.comBrokerages Set Novavax, Inc. (NASDAQ:NVAX) Price Target at $14.29September 28, 2025 | americanbankingnews.comNovavax Inc. stock underperforms Thursday when compared to competitorsSeptember 25, 2025 | marketwatch.comNovavax, Inc. (NASDAQ:NVAX) Given Consensus Rating of "Hold" by BrokeragesSeptember 25, 2025 | marketbeat.comKingstone Capital Partners Texas LLC Takes $1.02 Million Position in Novavax, Inc. $NVAXSeptember 22, 2025 | marketbeat.comChallenging Market Dynamics and Regulatory Hurdles Lead to Sell Rating for NovavaxSeptember 21, 2025 | tipranks.comNovavax: Endlessly Frustrating, Endlessly Fascinating - Warrants Rating UpgradeSeptember 18, 2025 | seekingalpha.comThe Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its DebutSeptember 18, 2025 | investors.comU.S. health insurers pledge continuing coverage of COVID shots ahead of ACIP meetingSeptember 17, 2025 | msn.comNovavax (NASDAQ:NVAX) Trading Up 5.1% - Time to Buy?September 17, 2025 | marketbeat.comGoldman Sachs Group Inc. Has $5.25 Million Stake in Novavax, Inc. $NVAXSeptember 17, 2025 | marketbeat.comWhy Avoid Pfizer, BioNTech, Novavax, and ModernaSeptember 15, 2025 | baystreet.caBayforest Capital Ltd Purchases New Stake in Novavax, Inc. $NVAXSeptember 13, 2025 | marketbeat.comPark West Asset Management LLC Acquires New Position in Novavax, Inc. $NVAXSeptember 8, 2025 | marketbeat.comNorthern Trust Corp Reduces Position in Novavax, Inc. $NVAXSeptember 8, 2025 | marketbeat.comNovavax, Inc. (NVAX) Presents At Cantor Global Healthcare Conference 2025 TranscriptSeptember 4, 2025 | seekingalpha.comNuvaxovid® Now Approved in Japan Triggering Takeda Milestone PaymentSeptember 4, 2025 | prnewswire.comNovavax ‘applauds’ President Trump’s call for available COVID-19 vaccine dataSeptember 4, 2025 | msn.comNovavax to Participate in the Cantor Global Healthcare ConferenceSeptember 3, 2025 | finance.yahoo.comOMERS ADMINISTRATION Corp Takes $1.28 Million Position in Novavax, Inc. $NVAXSeptember 3, 2025 | marketbeat.comOptimistic Outlook on Novavax: Strategic Positioning and Vaccine Developments Drive Buy RatingSeptember 2, 2025 | tipranks.comRafferty Asset Management LLC Sells 80,502 Shares of Novavax, Inc. $NVAXSeptember 2, 2025 | marketbeat.comInvesco Ltd. Boosts Stake in Novavax, Inc. $NVAXSeptember 2, 2025 | marketbeat.comFY2025 Earnings Forecast for Novavax Issued By HC WainwrightSeptember 2, 2025 | marketbeat.comNuveen LLC Purchases New Position in Novavax, Inc. $NVAXSeptember 1, 2025 | marketbeat.comNovavax, Inc. (NASDAQ:NVAX) Given Consensus Recommendation of "Hold" by BrokeragesSeptember 1, 2025 | marketbeat.comQ3 Earnings Forecast for Novavax Issued By HC WainwrightAugust 31, 2025 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Novavax (NASDAQ:NVAX)August 30, 2025 | marketbeat.comKohl’s, Bill.com, Novavax, Jazz, Nvidia: Trending by AnalystsAugust 30, 2025 | tipranks.comNovavax, Inc. (NVAX) Wins FDA Approval for Nuvaxovid BLAAugust 29, 2025 | finance.yahoo.comRobert Kennedy Jr. Announces End Of FDA Covid Mandates – Clears Moderna, Pfizer, Novavax For High-Risk GroupsAugust 28, 2025 | msn.comNovavax (NVAX) Is Up After FDA Approves Updated Nuvaxovid for Key High-Risk Groups—What's ChangedAugust 28, 2025 | finance.yahoo.comNovavax, Inc. (NVAX) Launches Protein-Based Vaccine for High-Risk AdultsAugust 28, 2025 | insidermonkey.com511,742 Shares in Novavax, Inc. $NVAX Purchased by Jump Financial LLCAugust 28, 2025 | marketbeat.comRFK Jr. Rescinds Emergency Authorizations For COVID-19 VaccinesAugust 27, 2025 | benzinga.comNovavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.August 27, 2025 | prnewswire.comNovavax, Inc. $NVAX Shares Sold by Vanguard Group Inc.August 25, 2025 | marketbeat.comNovavax (NVAX): How Debt Extension and Fresh Funding Shape Its Current ValuationAugust 24, 2025 | finance.yahoo.comNotable healthcare headlines for the week: Novo Nordisk, Medtronic, Novavax in focusAugust 24, 2025 | seekingalpha.comNovavax Faces Stock Slump Amid DowngradeAugust 23, 2025 | tipranks.comNovavax Shares Are Trading Higher Thursday: What's Going On?August 22, 2025 | benzinga.comWhat the Options Market Tells Us About NovavaxAugust 22, 2025 | benzinga.comBank of America Reiterates Underperform Rating for Novavax (NASDAQ:NVAX)August 22, 2025 | marketbeat.comNovavax Announces $225M Convertible Senior Notes IssuanceAugust 21, 2025 | tipranks.comNovavax announces convertible debt refinancingAugust 21, 2025 | seekingalpha.comNovavax Announces Convertible Debt RefinancingAugust 21, 2025 | prnewswire.com Get Novavax News Delivered to You Automatically Sign up to receive the latest news and ratings for NVAX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NVAX Media Mentions By Week NVAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVAX News Sentiment▼0.370.53▲Average Medical News Sentiment NVAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVAX Articles This Week▼711▲NVAX Articles Average Week Get the Latest News and Ratings for NVAX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Novavax and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Moderna News Ocugen News Vaxart News Johnson & Johnson News Pfizer News Alkermes News Ligand Pharmaceuticals News Amicus Therapeutics News Celldex Therapeutics News MannKind News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVAX) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | SponsoredURGENT: The Market's 3 Red Flags Are FlashingThe warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gol...StockEarnings | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novavax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novavax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVAX Stock Alerts